The first Pfizer trade was made in Q4 2015.
Since then John Paulson bought shares three more times and sold shares on three occasions. The investor sold all their shares in Q2 2017 and doesn't own any shares in Pfizer anymore.
Avg closing price
Price range
Sold -408 Thousand shares
Q2 2017
Avg closing price
$33.24
Price range
$31.75
-
$34.34
Increased shares by 15.7% (+55.3 Thousand shares)
Q1 2017
Avg closing price
$33.23
Price range
$31.15
-
$34.63
Increased shares by 39.8% (+100 Thousand shares)
Q4 2016
Avg closing price
$32.18
Price range
$29.89
-
$33.90
Sold 50.6% shares (-258 Thousand shares)
Q3 2016
Avg closing price
$35.24
Price range
$33.32
-
$37.31
Sold 63.0% shares (-868 Thousand shares)
Q2 2016
Avg closing price
$33.64
Price range
$30.04
-
$35.31
Increased shares by 117.8% (+745 Thousand shares)
Q1 2016